Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading Up 2.5%

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXFGet Rating)’s stock price was up 2.5% during trading on Monday . The stock traded as high as $0.93 and last traded at $0.93. Approximately 10,000 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 13,728 shares. The stock had previously closed at $0.91.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on MEDXF shares. Raymond James raised their price target on shares of Medexus Pharmaceuticals from C$3.50 to C$4.00 in a research note on Friday, March 10th. Stifel Nicolaus lowered shares of Medexus Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Thursday, February 9th.

Medexus Pharmaceuticals Stock Performance

The company’s 50 day moving average price is $1.04 and its 200-day moving average price is $1.29.

About Medexus Pharmaceuticals

(Get Rating)

Medexus Pharmaceuticals, Inc operates as a pharmaceutical company, which provides healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The firm products include Rasuvo, Ixinity and Triamcinolone Hexacetonide. The company was founded by Sylvain Chretien in January 2008 and is headquartered in Bolton, Canada.

Featured Stories

Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with's FREE daily email newsletter.